Novel Thiourea and Oxime Ether Isosteviol-Based Anticoagulants: MD Simulation and ADMET Prediction
Activated blood coagulation factor X (FXa) plays a critical initiation step of the blood-coagulation pathway and is considered a desirable target for anticoagulant drug development. It is reversibly inhibited by nonvitamin K antagonist oral anticoagulants (NOACs) such as apixaban, betrixaban, edoxab...
Saved in:
Main Authors: | Marcin Gackowski (Author), Mateusz Jędrzejewski (Author), Sri Satya Medicharla (Author), Rajesh Kondabala (Author), Burhanuddin Madriwala (Author), Katarzyna Mądra-Gackowska (Author), Renata Studzińska (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ether Derivatives of Naringenin and Their Oximes as Factors Modulating Bacterial Adhesion
by: Anna Duda-Madej, et al.
Published: (2023) -
Thiourea Derivatives as Estrogen Receptor Alpha Inhibitors for Breast Cancer Therapy: An In Silico Evaluation with ADMET Prediction and Molecular Docking
by: Hestining Puspaweni, et al.
Published: (2024) -
Isosteviol: A potential cardioprotective agent
by: Jovanović Aleksandar
Published: (2024) -
New 2-Aryl-1,4-naphthoquinone-1-oxime Methyl Ether Compound Induces Microtubule Depolymerization and Subsequent Apoptosis
by: Hiromi Sato, et al.
Published: (2012) -
Erythrocyte Partitioning Profile of Isosteviol in Human and Rat Blood
by: Ayorinde Adehin, PhD, et al.
Published: (2019)